Log In
Print this Print this

shRNAi for cancer associated chronic pain

  Manage Alerts
Collapse Summary General Information
Company Benitec Biopharma Ltd.
Molecular Target
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: shRNA
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat cancer associated chronic pain
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today